Unity Biotechnology Valuation
| UBXDelisted Stock | USD 0.16 0.01 6.67% |
Unity Biotechnology seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Unity Biotechnology from inspecting the company fundamentals such as Shares Owned By Institutions of 17.10 %, return on equity of -2.31, and Shares Outstanding of 17.21 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Unity Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Unity Biotechnology is based on 3 months time horizon. Increasing Unity Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Unity Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Unity Stock. However, Unity Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.16 | Real 0.15 | Hype 0.16 |
The intrinsic value of Unity Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Unity Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Unity Biotechnology helps investors to forecast how Unity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Unity Biotechnology more accurately as focusing exclusively on Unity Biotechnology's fundamentals will not take into account other important factors: About Unity Biotechnology Valuation
Our relative valuation model uses a comparative analysis of Unity Biotechnology. We calculate exposure to Unity Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Unity Biotechnology's related companies.Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Unity Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Unity Stock
If you are still planning to invest in Unity Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Unity Biotechnology's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |